BRIEF—Roche Genentech Innovation Center Boston launched

Swiss pharma giant Roche has announced the launch of the Roche Genentech Innovation Center Boston, USA, at Harvard’s Enterprise Research Campus in Allston which will further strengthen the long-standing partnership in areas such as disease biology, engineering, and artificial intelligence / machine learning.

The Roche Genentech Innovation Center Boston will serve as Roche’s cardiovascular, renal, and metabolism (CVRM) hub, establishing a significant end-to-end R&D presence in CVRM. It will also support some of Roche’s and Genentech’s efforts in AI and data science to accelerate drug discovery and development.

Roche chief executive Thomas Schinecker commented: “Our new innovation center builds upon our long-standing collaboration with Harvard and enables us to leverage the exceptional talent in the Boston area. By investing in a new cardiovascular, renal, and metabolism center of excellence, along with data science and AI capabilities at this strategic location, we aim to accelerate Roche`s and Genentech`s research efforts and leverage the Boston innovation ecosystem. Roche has a significant presence in the US and this new center is one of a number of research and manufacturing investments that Roche is making in the US through Genentech and diagnostics.”